Literature DB >> 12078053

[Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index].

Koji Nishiya1, Mitsuru Nishiyama, Angela Chang, Atsushi Shinto, Kozo Hashimoto.   

Abstract

Leptin, a 16-kD protein of the ob gene product, is produced by adipose tissue and acts on the hypothalamus to suppress neuropeptide Y secretion which reduces the appetite. It has been demonstrated that serum leptin levels in healthy subjects are correlated with body mass index(BMI). Leptin is also produced by stimulation of inflammatory cytokines such as tumor necrosis factor(TNF)-alpha and interleukin(IL)-1. Rheumatoid arthritis(RA) is one of the chronic inflammatory diseases in which high serum cytokine levels are noted. In this study, we measured serum leptin levels(s-leptin) by RIA kit in 20 healthy subjects (10 males and 10 females) and 49 RA patients(14 males and 35 females) and the markers for joint inflammation such as ESR and CRP. There was no difference in s-leptin between controls(male: mean +/- SD = 5.6 +/- 3.0 ng/ml; female: 7.8 +/- 4.5 ng/ml) and RA patients(male: 4.9 +/- 3.2 ng/ml; female: 9.1 +/- 5.7 ng/ml). S-leptin was correlated with BMI in both healthy subjects and RA patients. However, there was no correlation between s-leptin and the values of ESR or CRP, disease stages in RA patients. In conclusion, s-leptin in RA patients reflects BMI but not joint inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12078053

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  21 in total

Review 1.  Roles of leptin in bone metabolism and bone diseases.

Authors:  Xu Xu Chen; Tianfu Yang
Journal:  J Bone Miner Metab       Date:  2015-03-18       Impact factor: 2.626

2.  Leptin as an obesity marker in rheumatoid arthritis.

Authors:  Maria Fernanda Brandão de Resende Guimarães; Marcus Vinícius Melo de Andrade; Carla Jorge Machado; Érica Leandro Marciano Vieira; Maria Raquel da Costa Pinto; Antônio Lúcio Teixeira Júnior; Adriana Maria Kakehasi
Journal:  Rheumatol Int       Date:  2018-06-11       Impact factor: 2.631

3.  Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis.

Authors:  C Popa; M G Netea; T R D S Radstake; P L van Riel; P Barrera; J W M van der Meer
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

4.  Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion.

Authors:  Shereen M Olama; Mohammed K Senna; Mohammed Elarman
Journal:  Rheumatol Int       Date:  2010-12-08       Impact factor: 2.631

5.  Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis ?

Authors:  Sami Hizmetli; Mustafa Kisa; Nurdagül Gokalp; M Zahir Bakici
Journal:  Rheumatol Int       Date:  2006-11-11       Impact factor: 2.631

6.  Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis.

Authors:  Bozena Targońska-Stepniak; Magdalena Dryglewska; Maria Majdan
Journal:  Rheumatol Int       Date:  2009-07-12       Impact factor: 2.631

7.  Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity.

Authors:  Bozena Targońska-Stepniak; Maria Majdan; Magdalena Dryglewska
Journal:  Rheumatol Int       Date:  2007-10-30       Impact factor: 2.631

Review 8.  Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis.

Authors:  G Tian; J-N Liang; H-F Pan; D Zhou
Journal:  Ir J Med Sci       Date:  2014-02-09       Impact factor: 1.568

9.  Serum leptin in systemic lupus erythematosus.

Authors:  M Wisłowska; M Rok; K Stepień; A Kuklo-Kowalska
Journal:  Rheumatol Int       Date:  2008-01-15       Impact factor: 2.631

10.  Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis.

Authors:  Jana Jurcovicova; Karol Svik; Sona Scsukova; Katarina Bauerova; Jozef Rovensky; Maria Stancikova
Journal:  Rheumatol Int       Date:  2009-01-21       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.